Newsletter Archives > ChiroPlanet.com Monthly Health Newsletter: April 2010 Health Newsletter

April 2010 Health Newsletter


Current Articles

» Heart Health Nutritional Support
» Symptoms During Pregnancy With Few Adverse Effects
» It’s the Inflammation, Stupid!
» LIVE ~ LOVE ~ LAUGH
» Manipulation Also Effective For Shoulder Problems
» Spinal Surgery Costs Surge
» Prescription Drug Overdoses Increase
» Sleep and Lose Weight

Heart Health Nutritional Support
br logo nutriwest
Cardioplex:  Vitamins and phytochemically-rich herbs to help maintain a healthy heart
Core Level Heart:
Nutritional support of the cardiac muscles
Homocysteine Redux:  Nutritional support of the cardiac muscles

Pure
Calcium (citrate): Highly absorbable calcium; reduces the risk of osteoporosis, supports cardiovascular   and colon health
CoQ10:  Energy for cardiovascular health
l-Carnitine:  Cardiovascular and endurance support

Biotics
ADHS:  Supports normal cortisol levels
L-Carnitine HCL:  Plays a critical role in fat metabolism and eneygy productions, therefore supports healthy heart function.
Mg Zyme:  Magnesium support for proper cardiac support

PLEASE FEEL FREE TO CONTACT THE OFFICE REGARDING ADDITIONAL HEART HEALTH NUTRITIONAL SUPPORT OR ASK THE DOCTOR ON YOUR NEXT VISIT

Author: Clearwater Chiropractic & Acupuncture P.A.
Source: March 2010; Vol 2, No. 1
Copyright: Dr. Susan J. Aubuchon 2010


page toppage toppage top




Symptoms During Pregnancy With Few Adverse Effects

Targeted acupuncture may offer women with major depression a safe and effective alternative to antidepressant medication, new research suggests.

Investigators at Stanford University School of Medicine in California found that women with major depressive disorder treated with depression-specific acupuncture had a 63% response rate after 12 sessions compared with a 44.3% response rate in 2 combined control groups who were treated with either acupuncture not known to help alleviate depressive symptoms or Swedish massage.

"Pregnancy just by its nature can bring out some underlying psychiatric and emotional issues ... but treatment of depression during pregnancy is critically important so that a woman can maintain her sense of well being and take good care of herself, her fetus and, someday, her child," study coauthor Deirdre Lyell, MD, Stanford University School of Medicine, said in a statement.

Led by Rachel Manber, PhD, the study was published in the March issue of Obstetrics & Gynecology.

Response Rates Significantly Higher

For the study, investigators randomized 150 women whose pregnancies were between 12 and 30 weeks of gestation and who met Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria for major depressive disorder and who scored at least 14 on the 17-item Hamilton Rating Scale for Depression.

Of the 141 women who eventually entered the study, 52 received depression-specific acupuncture, 49 received control acupuncture, and 49 others received Swedish massage.

Treatments were provided twice a week for the first 4 weeks and then weekly thereafter for 4 additional weeks, with each session lasting about 25 minutes.

The investigators found that response rates were significantly higher in women who received depression-specific acupuncture than for either control group. Response rates in women randomized to the 2 control interventions did not differ significantly from each other at 37.5% for the control acupuncture group vs 50% for the massage group.

On the other hand, remission rates did not differ significantly between women who received depression-specific acupuncture at 34.8% and the combined control groups at 29.5%. They also did not differ between those assigned to the control acupuncture group at 27.5% or the massage group at 31.2%.

Thirty-three of the study participants discontinued treatment before the study endpoint, 30% of them for reasons related to the pregnancy. Some women in both acupuncture groups reported transient discomfort at the point of needle insertion, and 1 woman experienced bleeding at the needle site.

Significantly fewer women who received massage reported any adverse effects compared with the 2 acupuncture groups.

Clinically Meaningful

The study authors point out that the benefits observed with depression-specific acupuncture can be considered "clinically meaningful" when assessed in a broader context of depression studies.

Although there are no randomized controlled trials of antidepressants being used during pregnancy, 1 randomized controlled trial found that interpersonal psychotherapy produced a 52% reduction in Hamilton Rating Scale for Depression scores and a 19% remission rate after 16 weeks of therapy, to which the currently study compares very favorably.

According to the study, antidepressant use during pregnancy doubled between 1999 and 2003, but many women are reluctant to take these medications because of safety concerns. In fact, in this particular study, 94% of the women involved expressed reluctance to take an antidepressant because of their pregnancy.

"Because there’s this concern about medication among pregnant women and their physicians, it’s important to find an alternative," said Dr. Manber.

Results from this study therefore suggest that this standardized acupuncture protocol could be considered a "viable treatment option" for depression during pregnancy, the investigators conclude.

Michael Thase, MD, University of Pennsylvania School of Medicine, cautions that findings from this study are preliminary, although they suggest that depression-specific acupuncture may have value in major depressive disorder in this patient population.

On the other hand, another study assessing depression-specific acupuncture in a broader population of men and women with major depressive disorder failed to find a significant effect from the modality, so evidence supporting acupuncture for the treatment of major depressive disorder is not consistent.

"Still there is reason to be cautious when prescribing antidepressants in pregnancy, and one has to weigh the pros and cons of using an antidepressant on an individual basis,” he told Medscape Psychiatry.

"If these promising findings are confirmed, it would be good to have another option to complement the focused forms of psychotherapy which are currently used for antenatal depression," he added.

The study was funded by the Agency for Healthcare Research and Quality. The study authors and Dr. Thase have disclosed no relevant financial relationships.

Obstet Gynecol. 2010;115:511-520.

Author: Pam Harrison
Source: © 2010 Medscape, LLC
Copyright: Medscape Medical News 2010


page toppage toppage top




It’s the Inflammation, Stupid!

In the 1992 presidential campaign, Bill Clinton was a heavy underdog to popular incumbent George H. W. Bush. Bush was considered unbeatable due to foreign policy successes including the end of the Cold War and routing Saddam Hussein in the first Gulf War. But Bush’s approval ratings, which had been in the 90 percent range, began to dip as his campaign ignored the economic recession. Clinton’s campaign manager James Carville’s now famous campaign slogan, "It’s the economy stupid," helped turn the tide and Bill Clinton became the forty-second American president.

Just like George Bush’s 1992 presidential campaign, today’s medical community continues to promote the medical myths associated with cholesterol while ignoring the real cause of cardiovascular disease, inflammation.

Conventional opinion and current medical dogma holds that low cholesterol, especially low LDL cholesterol, reduces the risk and incidence of heart disease and stroke. This belief is so entrenched in the medical community that the FDA now approves drugs to prevent heart disease, as it did with Zetia and Vytorin, solely on the evidence that they lower LDL cholesterol levels. Zetia has never been proven to reduce heart attacks, strokes or death. Statin drugs help reduce the risk of heart attack and stroke for those who’ve already had a cardiac event (one percent over placebo) but fail to reduce death in women, the elderly, men over the age of 47, and in men without cardiovascular risk factors.

A 2006 study in The Archives of Internal Medicine looked at seven trials of statin use in nearly 43,000 patients, mostly middle-aged men without heart disease. In that review, statins didn’t lower mortality.

Nor did they in a study known as Prosper, published in The Lancet in 2002, which studied statin use in people seventy and older. Nor did they in a 2004 review in The Journal of the American Medical Association, which looked at thirteen studies of nearly 20,000 women, both healthy and with established heart disease.

Despite a growing voice of reason, which became even louder after the recently released Enhance study, the cholesterol zealots continue to view cardiovascular disease with tunnel vision. This myopic vision fuels the cholesterol drug war which rages on as each pharmaceutical company seeks to gain economic gain in the 40 billion dollar a year lipid lowering drug market.

In an attempt to take on the cholesterol Goliath, Pfizer’s Lipitor (10 billion dollars in sales annually), Merck and Schering-Plough combined their cholesterol lowering drugs, Zocor and Zetia, to form the "super drug" known as Vytorin. Vytorin’s goal was to lower LDL cholesterol more than either drug could alone. Zetia lowers blood cholesterol by blocking the absorption of dietary cholesterol from the intestines. Zetia used alone is modestly effective in lowering LDL cholesterol by approximately 17 percent. Zocor alone lowers LDL levels by 36 percent—similar to Lipitor.

The hope was that by lowering LDL to dramatically low levels, Vytorin would do a better job of slowing the accumulation of fatty plaques in the arteries. Vytorin did, in fact, reduce LDL—by a whopping 51 percent (similar to AstraZeneca’s Crestor).

However, the two-year "Enhance" trial failed to prove that Vytorin is better than Zocor alone for slowing plaque accumulation; instead atherosclerosis worsened in those taking Vytorin.

Merck and Schering-Plough suppressed this finding for twenty months.

The study results were not revealed until the two drug companies were pressured into doing so by an article in The New York Times and a Congressional inquiry. The marketers of Vytorin said they had nothing to hide. It’s hard to believe they weren’t just a little reluctant to publish their highly anticipated study. The news that Vytorin, which retails for $100 a month and did $2 billion in sales in 2007, was clinically inferior (perhaps even dangerous) to generic simvastatin (statin), costing less than $20 a month, obviously wasn’t what stockholders wanted to hear.

Merck and Schering-Plough are running full-page ads daily in the Times and Wall Street Journal, warning people not to be confused by a single study and to continue taking Vytorin. The advice was backed by the American Heart Association, which the Times reported receives nearly $2 million a year from Merck/Schering-Plough Pharmaceuticals.

Other LDL lowering drugs have bitten the dust in the last coupe of years as well.

Pfizer’s trial of its much-anticipated drug torcetrapib, which raised HDL, the good cholesterol, and lowered LDL, had to be stopped in 2006 because the drug caused heart attacks and strokes.

Estrogen replacement therapy, which is known to lower LDL cholesterol levels, failed to reduce the incidence of heart attack and stroke in clinical studies.

Ok, if cholesterol lowering isn’t the answer for everyone, why do statins help people with existing heart disease? Dr. James K. Liao of Brigham & Women’s Hospital in Cambridge, Massachusetts, has been investigating this question for over a decade. He suspects that statins have other biological effects. His research shows that statin drugs not only block cholesterol, but also an inflammation-generating enzyme known as rho-kinase.

When Liao reduced the rho-kinase levels in rats, they didn’t get heart disease. "Cholesterol lowering is not the reason for the benefit of statins," he concludes. Of course, there are dozens of inflammatory chemicals that play a role in triggering cardiovascular disease. Diet, health habits, our environment, even our personality may initiate inflammatory chemicals that perpetuate cardiovascular disease events.

Ralph Waldo Emerson once said, "People see only what they are prepared to see." As the evidence about inflammation and cardiovascular disease rises, will conventional medicine and the public at large be prepared to see that it’s not about lowering cholesterol but in reducing inflammation? Hopefully, "It’s the inflammation, stupid," will become a common slogan in the campaign to fight cardiovascular disease.

Rodger Murphree, D.C., has been in private practice since 1990. He is the founder of, and past clinic director for a large integrated medical practice, which was located on the campus of Brookwood Hospital in Birmingham, Alabama. He is the author of Treating and Beating Fibromyalgia and Chronic Fatigue Syndrome, Heart Disease What Your Doctor Won’t Tell You, and Treating and Beating Anxiety and Depression with Orthomolecular Medicine. He can be reached at www.treatingandbeating.com, by email at drrodgerm@yahoo.com or 1-205-879-2383.

References

1. Harriet Rosenberg and Danielle Allard "Evidence for Ca Women and statin use." Women and Health Protection June 2007.

2. Business Week magazine Lipitor cover story: "Do Cholesterol Drugs do any Good?" January 17, 2008.

3. TheHeart.org from Web MD www.theheart.org, see video blog of Eric J. Topol, MD, "Temple of the LDL Cholesterol."

4. "REPEAT/New Study Showed VYTORIN® Superior to Lipitor in Reducing LDL ‘’Bad’’ Cholesterol in Patients with Type II Diabetes at the Recommended Usual Starting Doses." Business Wire. June 12, 2006.

5. The International Network of Cholesterol Skeptics, www.thincs.org.

6. Rodger H. Murphree D.C., Heart Disease What Your Doctor Won’t Tell You. Harrison and Hampton Publishing Birmingham, AL. 2006.

Author: Dr. Rodger Murphree, D.C.
Source: TAC, Integrative Healthcare ,
Copyright: Volume 30, Issue 4 2010


page toppage toppage top




LIVE ~ LOVE ~ LAUGH

Shary’s corner
 

                       LIVE                        LOVE                          LAUGH
Every day can be filled with meaning.  Take a moment, just the amount of time you need to take a deep breath and exhale slowly, to ask yourself what is my dream, and how will I get there from here?
What can you stop doing or do differently to simplify your life and make it more meaningful?  What is truly important to you?  Do you give some time each week to your true priorities?
Why not fill your life with love and laughter whenever you can?  There is no greater gift than the gift of loving others.  There is nothing wrong with taking some time for self-care too.  Love your pet?  Love walking out in nature?  Make time for your passions and those things that add value to your life.  Your body, mind and soul will thank you.
Do you have a mission in life?
Dream it.
Think about it.
                      Talk about it.
                                                 Commit to it.

 

Author: Clearwater Chiropractic & Acupuncture
Source: March 2010; Vol. 2, No 1
Copyright: Dr. Susan J. Aubuchon 2010


page toppage toppage top




Manipulation Also Effective For Shoulder Problems

It’s no secret chiropractic care works wonders for many suffering from back, neck and spinal related problems. However, many are unaware that chiropractic care also provides excellent results in a number of non-spinal related conditions including those related to the extremities. Manipulative treatments chiropractors often apply to the spine are similarly used by chiropractors on the joints of the extremities including the hip, knee, ankle, foot, hand, wrist, elbow and shoulder joints. Manipulation of these joints involves a safe, controlled and specific force that is skillfully applied in order to restore normal joint motion that in turn provides nutrients to the joint, reducing inflammation and pain. Researchers recently conducted a study to compare the outcomes of treating patients with shoulder complaints with usual care from a general practitioner (medical doctor) both with and without the additional care of manipulative therapy applied directly to the shoulder girdle. At 12 weeks after initiating care, those receiving the additional manipulative therapy had better outcomes related to shoulder pain, neck pain. At 26 weeks, those receiving the additional manipulative therapy had statistically superior outcomes in shoulder pain, shoulder mobility and mobility of the neck. If you’re suffering from extra-spinal problems such as problems with the legs, hips or arms, call our office for an appointment to see if safe, natural and effective chiropractic care might be the solution for you!

Author: ChiroPlanet.com
Source: JMPT. Volume 33, Issue 2, Pages 96-101 (February 2010).
Copyright: ProfessionalPlanets.com LLC 2010


page toppage toppage top




Spinal Surgery Costs Surge

Older patients with lower back pain are increasingly getting more complex and costlier spinal fusion surgeries, resulting in higher rates of life-threatening complications and increasing costs for the healthcare system, U.S. researchers said on Tuesday. A study of records from the federal Medicare program for the elderly and disabled between 2002 and 2007 revealed a 15-fold increase in the rate of complex surgeries to treat spinal stenosis -- a common condition in the elderly in which the spinal canal narrows, causing pain in the back and legs. And while the number of overall procedures to treat this problem dipped during the period, hospital charges for those surgeries rose by 40 percent on an inflation-adjusted basis, Dr. Richard Deyo of the Oregon Health and Science University in Portland and his colleagues reported in the Journal of the American Medical Association. In a telephone interview Deyo said the trend in part is related to the introduction of new technology, such as spinal cages and special screws used to fuse vertebrae together. But it also reflects savvy marketing by orthopedic device makers such as Stryker Corp., Medtronic Inc. and Johnson & Johnson's DePuy unit, that has convinced surgeons more complex surgery is better, Deyo said. Studies, however, suggest complex spinal fusion surgeries offer little benefit over simpler procedures for most patients, and increase the risk of complications. "It is driving up the cost of care without much evidence that it is improving care," Deyo said. A study last year published in JAMA found that the cost of treating spine problems in the United States rose 65 percent in the past decade to $85.9 billion a year, rivaling the economic burden of treating cancer, which costs $89 billion. Yet, for all of the spending, they found people with spine problems actually felt worse. Deyo's team studied three specific surgical procedures for lumbar stenosis: decompression, in which part of the vertebrae is removed to ease pressure on nerve roots; simple fusion, in which one or two discs are fused together through an incision in the back or abdomen; and complex fusion, in which more than 3 vertebrae are treated or the surgery is done from both the back and front. Overall, the procedure rate fell 1.4 percent during the study period, but rates of complex fusion surgery increased from 1.3 per 100,000 patients to 19.9 per 100,000. "What happened was the most complex type of surgery increased 15-fold over that period of time, a far more rapid increase than we could explain just on the basis of more severe disease," Deyo said. "What we also found is these more complex operations are associated with a higher rate of serious complications." Patients in the study who had a complex fusion procedure had a nearly three times higher odds of a life-threatening complication compared with those who only got decompression. And overall hospital charges rose 40 percent in inflation-adjusted dollars, the team found. Dr. Eugene Carragee of the Stanford University School of Medicine in California said in a commentary that the study should remind patients, doctors and insurance companies to carefully weigh the options for spinal surgery. "... the efficacy of basic spinal techniques must be assessed carefully against the plethora of unproven but financially attractive alternatives," Carragee wrote, noting that "financial incentives and market forces do not favor this careful assessment before technologies are widely adopted."

Author: Julie Steenhuysen
Source: Reuters Health. April 7, 2010.
Copyright: Reuters 2010


page toppage toppage top




Prescription Drug Overdoses Increase

According to a newly released report in the American Journal of Preventative Medicine, the number of Americans ending up in the hospital due to overdoses from prescribed painkillers, sedatives and tranquilizers is rising steeply. In just 8 years, 1999 to 2006, hospital admissions from prescription drug overdoses increased an alarming 65 percent from 43,000 to 71,000. Another stunning statistic - Unintentional prescription drug overdoses surpassed motor vehicle crashes as the leading cause of unintentional injury death in 2005 for those 35 to 54 years of age. There are many more jaw dropping statistics listed in the report that highlight the dangers of many prescription drugs, especially those prescribed for the purpose of reducing pain.

Author: ChiroPlanet.com
Source: American Journal of Preventive Medicine, April 2010.
Copyright: ProfessionalPlanets.com LLC 2010


page toppage toppage top




Sleep and Lose Weight

What if you could simply lose weight by getting more sleep, would you be interested? Well, new research indicates that this isn’t too far off. Researchers have found those who don’t get adequate sleep actually consume more calories than those who do. Researchers followed 12 healthy young men for two 48-hour sessions while recording their sleep, calorie consumption and activity level. They found those who got 4 hours of sleep versus 8 hours of sleep actually consumed 22 percent more calories. Thus, the lack of adequate sleep resulted in a significant increase in their caloric intake. Other studies have also found shorter sleep duration is associated with higher body mass index but this is the first to study the effects of sleep duration to calorie consumption in normal-weight individuals.

Author: ChiroPlanet.com
Source: American Journal of Clinical Nutrition, online March 31, 2010.
Copyright: ProfessionalPlanets.com LLC 2010


page toppage toppage top






Articles 1-8 of 8 << first < previous next > last >